Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Imfinzi as first-line treatment for extensive-stage SCLC

March 30, 2020

FDA approves Zeposia as oral treatment for relapsing forms of multiple sclerosis

March 27, 2020

Japan first in world to approve Viltepso for Duchenne muscular dystrophy

March 26, 2020

Velexbru approved in Japan for recurrent or refractory primary central nervous system lymphoma

March 26, 2020

Dupixent approved for additional indication of chronic rhinosinusitis with nasal polyp

March 26, 2020

Intravitreal Eylea approved for neovascular glaucoma

March 26, 2020

Japanese approval of Tepmetko for advanced NSCLC with METex14 skipping alterations

March 25, 2020

Health Canada grants first global regulatory approval for Cabenuva

March 23, 2020

FDA approves Epclusa for pediatric patients with hepatitis C

March 20, 2020

Almonertinib receives approval in China for EGFR T790M-mutant NSCLC

March 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...